Reprint of: Monocyte subsets in man and other species

Cellular Immunology

Volumn 291, Issue 1-2, 2014, Pages 11-15

  Ziegler Heitbrock, Loems ^a  

^a Helmholtz Zentrum Muenchen   (Germany)

Author keywords

Innate immunity

Indexed keywords

ANTIGEN;

ANIMAL CELL; ARTICLE; COW; FLOW CYTOMETRY; GENE EXPRESSION; HORSE; HUMAN; HUMAN CELL; MONOCYTE; MOUSE; NONHUMAN; PHENOTYPE; RAT; SWINE;

EID: 84908260822     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2014.06.008     Document Type: Article

References (51)

1. Ahuja V., Miller S.E., Howell D.N. Identification of two subpopulations of rat monocytes expressing disparate molecular forms and quantities of CD43. Cell. Immunol. 1995, 163:59-69.
2. Ancuta P., Rao R., Moses A., Mehle A., Shaw S.K., Luscinskas F.W., Gabuzda D. Fractalkine preferentially mediates arrest and migration of CD16+ monocytes. J. Exp. Med. 2003, 197:1701-1707.
3. Auffray C., Fogg D., Garfa M., Elain G., Join-Lambert O., Kayal S., Sarnacki S., Cumano A., Lauvau G., Geissmann F. Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science 2007, 317:666-670.
4. Balow J.E., Hurley D.L., Fauci A.S. Immunosuppressive effects of glucocorticosteroids: differential effects of acute vs chronic administration on cell-mediated immunity. J. Immunol. 1975, 114:1072-1076.
5. Belge K.U., Dayyani F., Horelt A., Siedlar M., Frankenberger M., Frankenberger B., Espevik T., Ziegler-Heitbrock L. The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF. J. Immunol. 2002, 168:3536-3542.
6. Burke B., Ahmad R., Staples K.J., Snowden R., Kadioglu A., Frankenberger M., Hume D.A., Ziegler-Heitbrock L. Increased TNF expression in CD43++ murine blood monocytes. Immunol. Lett. 2008, 118:142-147.
7. Coquillard G., Patterson B.K. Determination of hepatitis C virus-infected, monocyte lineage reservoirs in individuals with or without HIV coinfection. J. Infect. Dis. 2009, 200:947-954.
8. Dayyani F., Belge K.U., Frankenberger M., Mack M., Berki T., Ziegler-Heitbrock L. Mechanism of glucocorticoid-induced depletion of human CD14+CD16+ monocytes. J. Leukoc. Biol. 2003, 74:33-39.
9. Fabriek B.O., Dijkstra C.D., van den Berg T.K. The macrophage scavenger receptor CD163. Immunobiology 2005, 210:153-160.
10. Fairbairn L., Kapetanovic R., Beraldi D., Sester D.P., Tuggle C.K., Archibald A.L., Hume D.A. Comparative analysis of monocyte subsets in the pig. J. Immunol. 2013, 190:6389-6396.
11. Fingerle-Rowson G., Angstwurm M., Andreesen R., Ziegler-Heitbrock H.W. Selective depletion of CD14+ CD16+ monocytes by glucocorticoid therapy. Clin. Exp. Immunol. 1998, 112:501-506.
12. Fingerle G., Pforte A., Passlick B., Blumenstein M., Strobel M., Ziegler-Heitbrock H.W. The novel subset of CD14+/CD16+ blood monocytes is expanded in sepsis patients. Blood 1993, 82:3170-3176.
13. Frankenberger M., Hofer T.P., Marei A., Dayyani F., Schewe S., Strasser C., Aldraihim A., Stanzel F., Lang R., Hoffmann R., et al. Transcript profiling of CD16-positive monocytes reveals a unique molecular fingerprint. Eur. J. Immunol. 2012, 42:957-974.
14. Geissmann F., Jung S., Littman D.R. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003, 19:71-82.
15. Grage-Griebenow E., Lorenzen D., Fetting R., Flad H.D., Ernst M. Phenotypical and functional characterization of Fc gamma receptor I (CD64)-negative monocytes, a minor human monocyte subpopulation with high accessory and antiviral activity. Eur. J. Immunol. 1993, 23:3126-3135.
16. Heron M., Grutters J.C., van Velzen-Blad H., Veltkamp M., Claessen A.M., van den Bosch J.M. Increased expression of CD16, CD69, and very late antigen-1 on blood monocytes in active sarcoidosis. Chest 2008, 134:1001-1008.
17. Hussen J., Duvel A., Sandra O., Smith D., Sheldon I.M., Zieger P., Schuberth H.J. Phenotypic and functional heterogeneity of bovine blood monocytes. PLoS One 2013, 8:e71502.
18. Ingersoll M.A., Spanbroek R., Lottaz C., Gautier E.L., Frankenberger M., Hoffmann R., Lang R., Haniffa M., Collin M., Tacke F., et al. Comparison of gene expression profiles between human and mouse monocyte subsets. Blood 2010, 115:e10-e19.
19. Jaworowski A., Kamwendo D.D., Ellery P., Sonza S., Mwapasa V., Tadesse E., Molyneux M.E., Rogerson S.J., Meshnick S.R., Crowe S.M. CD16+ monocyte subset preferentially harbors HIV-1 and is expanded in pregnant Malawian women with Plasmodium falciparum malaria and HIV-1 infection. J. Infect. Dis. 2007, 196:38-42.
20. Kabithe E., Hillegas J., Stokol T., Moore J., Wagner B. Monoclonal antibodies to equine CD14. Vet. Immunol. Immunopathol. 2010, 138:149-153.
21. Katayama K., Matsubara T., Fujiwara M., Koga M., Furukawa S. CD14+CD16+ monocyte subpopulation in Kawasaki disease. Clin. Exp. Immunol. 2000, 121:566-570.
22. Kim W.K., Sun Y., Do H., Autissier P., Halpern E.F., Piatak M., Lifson J.D., Burdo T.H., McGrath M.S., Williams K. Monocyte heterogeneity underlying phenotypic changes in monocytes according to SIV disease stage. J. Leukoc. Biol. 2010, 87:557-567.
23. Korkosz M., Bukowska-Strakova K., Sadis S., Grodzicki T., Siedlar M. Monoclonal antibodies against macrophage colony-stimulating factor diminish the number of circulating intermediate and nonclassical (CD14(++)CD16(+)/CD14(+)CD16(++)) monocytes in rheumatoid arthritis patient. Blood 2012, 119:5329-5330.
24. Kwissa M., Nakaya H.I., Oluoch H., Pulendran B. Distinct TLR adjuvants differentially stimulate systemic and local innate immune responses in nonhuman primates. Blood 2012, 119:2044-2055.
25. Lenzo J.C., Turner A.L., Cook A.D., Vlahos R., Anderson G.P., Reynolds E.C., Hamilton J.A. Control of macrophage lineage populations by CSF-1 receptor and GM-CSF in homeostasis and inflammation. Immunol. Cell Biol. 2012, 90:429-440.
26. MacDonald K.P., Palmer J.S., Cronau S., Seppanen E., Olver S., Raffelt N.C., Kuns R., Pettit A.R., Clouston A., Wainwright B., et al. An antibody against the colony-stimulating factor 1 receptor depletes the resident subset of monocytes and tissue- and tumor-associated macrophages but does not inhibit inflammation. Blood 2010, 116:3955-3963.
27. Melgert B.N., Spaans F., Borghuis T., Klok P.A., Groen B., Bolt A., de Vos P., van Pampus M.G., Wong T.Y., van Goor H., et al. Pregnancy and preeclampsia affect monocyte subsets in humans and rats. PLoS One 2012, 7:e45229.
28. Moniuszko M., Bodzenta-Lukaszyk A., Kowal K., Lenczewska D., Dabrowska M. Enhanced frequencies of CD14++CD16+, but not CD14+CD16+, peripheral blood monocytes in severe asthmatic patients. Clin. Immunol. 2009, 130:338-346.
29. Moreno S., Alvarez B., Poderoso T., Revilla C., Ezquerra A., Alonso F., Dominguez J. Porcine monocyte subsets differ in the expression of CCR2 and in their responsiveness to CCL2. Vet. Res. 2010, 41:76.
30. Munn D.H., Bree A.G., Beall A.C., Kaviani M.D., Sabio H., Schaub R.G., Alpaugh R.K., Weiner L.M., Goldman S.J. Recombinant human macrophage colony-stimulating factor in nonhuman primates: selective expansion of a CD16+ monocyte subset with phenotypic similarity to primate natural killer cells. Blood 1996, 88:1215-1224.
31. Munn D.H., Garnick M.B., Cheung N.K. Effects of parenteral recombinant human macrophage colony-stimulating factor on monocyte number, phenotype, and antitumor cytotoxicity in nonhuman primates. Blood 1990, 75:2042-2048.
32. Noronha L.E., Harman R.M., Wagner B., Antczak D.F. Generation and characterization of monoclonal antibodies to equine CD16. Vet. Immunol. Immunopathol. 2012, 146:135-142.
33. Palframan R.T., Jung S., Cheng G., Weninger W., Luo Y., Dorf M., Littman D.R., Rollins B.J., Zweerink H., Rot A., et al. Inflammatory chemokine transport and presentation in HEV: a remote control mechanism for monocyte recruitment to lymph nodes in inflamed tissues. J. Exp. Med. 2001, 194:1361-1373.
34. Passlick B., Flieger D., Ziegler-Heitbrock H.W. Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood 1989, 74:2527-2534.
35. Sanchez C., Domenech N., Vazquez J., Alonso F., Ezquerra A., Dominguez J. The porcine 2A10 antigen is homologous to human CD163 and related to macrophage differentiation. J. Immunol. 1999, 162:5230-5237.
36. Schauer D., Starlinger P., Reiter C., Jahn N., Zajc P., Buchberger E., Bachleitner-Hofmann T., Bergmann M., Stift A., Gruenberger T., et al. Intermediate monocytes but not TIE2-expressing monocytes are a sensitive diagnostic indicator for colorectal cancer. PLoS One 2012, 7:e44450.
37. Scriba A., Schneider M., Grau V., van der Meide P.H., Steiniger B. Rat monocytes up-regulate NKR-P1A and down-modulate CD4 and CD43 during activation in vivo: monocyte subpopulations in normal and IFN-gamma-treated rats. J. Leukoc. Biol. 1997, 62:741-752.
38. Siedlar M., Strach M., Bukowska-Strakova K., Lenart M., Szaflarska A., Weglarczyk K., Rutkowska M., Baj-Krzyworzeka M., Pituch-Noworolska A., Kowalczyk D., et al. Preparations of intravenous immunoglobulins diminish the number and proinflammatory response of CD14+CD16++ monocytes in common variable immunodeficiency (CVID) patients. Clin. Immunol. 2011, 139:122-132.
39. Steppich B., Dayyani F., Gruber R., Lorenz R., Mack M., Ziegler-Heitbrock H.W. Selective mobilization of CD14(+)CD16(+) monocytes by exercise. Am. J. Physiol. Cell Physiol. 2000, 279:C578-C586.
40. Sunderkotter C., Nikolic T., Dillon M.J., Van Rooijen N., Stehling M., Drevets D.A., Leenen P.J. Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response. J. Immunol. 2004, 172:4410-4417.
41. Szaflarska A., Baj-Krzyworzeka M., Siedlar M., Weglarczyk K., Ruggiero I., Hajto B., Zembala M. Antitumor response of CD14+/CD16+ monocyte subpopulation. Exp. Hematol. 2004, 32:748-755.
42. Weber C., Belge K.U., von Hundelshausen P., Draude G., Steppich B., Mack M., Frankenberger M., Weber K.S., Ziegler-Heitbrock H.W. Differential chemokine receptor expression and function in human monocyte subpopulations. J. Leukoc. Biol. 2000, 67:699-704.
43. Wong K.L., Chen W., Balakrishnan T., Toh Y.X., Fink K., Wong S.C. Susceptibility and response of human blood monocyte subsets to primary dengue virus infection. PLoS One 2012, 7:e36435.
44. Wong K.L., Tai J.J., Wong W.C., Han H., Sem X., Yeap W.H., Kourilsky P., Wong S.C. Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. Blood 2011, 118:e16-e31.
45. Wrigley B.J., Shantsila E., Tapp L.D., Lip G.Y. CD14++CD16+ monocytes in patients with acute ischaemic heart failure. Eur. J. Clin. Invest. 2013, 43:121-130.
46. Yrlid U., Jenkins C.D., MacPherson G.G. Relationships between distinct blood monocyte subsets and migrating intestinal lymph dendritic cells in vivo under steady-state conditions. J. Immunol. 2006, 176:4155-4162.
47. Zawada A.M., Rogacev K.S., Rotter B., Winter P., Marell R.R., Fliser D., Heine G.H. SuperSAGE evidence for CD14++CD16+ monocytes as a third monocyte subset. Blood 2011, 118:e50-e61.
48. Ziegler-Heitbrock H.W., Appl B., Kafferlein E., Loffler T., Jahn-Henninger H., Gutensohn W., Nores J.R., McCullough K., Passlick B., Labeta M.O., et al. The antibody MY4 recognizes CD14 on porcine monocytes and macrophages. Scand. J. Immunol. 1994, 40:509-514.
49. Ziegler-Heitbrock L. The CD14+ CD16+ blood monocytes: their role in infection and inflammation. J. Leukoc. Biol. 2007, 81:584-592.
50. Ziegler-Heitbrock L., Ancuta P., Crowe S., Dalod M., Grau V., Hart D.N., Leenen P.J., Liu Y.J., MacPherson G., Randolph G.J., et al. Nomenclature of monocytes and dendritic cells in blood. Blood 2010, 116:e74-e80.
51. Ziegler-Heitbrock L., Hofer T.P. Toward a refined definition of monocyte subsets. Front. Immunol. 2013, 4:23.